Conference

Irisaida Mendez, Patient, Advocate

Karen Peterson, Founder and Chief Patient Advocate, Karen's Club

9:15AM - 9:40AM

Keynote: Decoding the Evolution of Patient Advocacy - A Decade of Progress

Roslyn Schneider, MD, MSc, FACP, FCCP, VP, Head of Global Patient Affairs, BioMarin Pharmaceutical Inc

Showing Events in 1 Track from 09:40am to 10:20am

Grand Opening of the Patients as Partners Exhibits

9:40AM - 10:20AM

Grand Opening of the Patients as Partners Exhibits, Networking and Breakfast

Showing Events in 1 Track from 10:20am to 12:35pm

Day 1 Morning Sessions Continued

10:20AM - 11:00AM

ASK THE PATIENTS: Patient and Caregiver Perspectives on Navigating Clinical Trials and Insights for Future Progress

Jaye Bea Smalley, Head, Patient Advocacy, Immunovant

Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes

Patrick Gee Sr, PhD, JLC, Patient Advocate, Founder & Chief Executive Hope Dealer, iAdvocate, Inc

Yvonne McLean Florence, MDiv, Patient Advocate and 2023 Elevate Ambassador, National Coalition for Cancer Survivorship

Emily Parks, Patient Advocate and Founder, POP!

11:00AM - 12:00PM

INTERACTIVE SESSION: Defining What Success Looks like for Engaging Participants and Enhancing Collaborations in Clinical Trials

Jamie Goldfarb, Patient, Advocate

Nisha Patel, MBA, Engagement Director, Global Clinical Operations, GSK

Peter Schaeffer, MBA, Digital and Process Optimization Leader, GSK

12:00PM - 12:05PM

Patients as Partners 5-Min Health Break

12:05PM - 12:35PM

Reducing Patient Burden: An Interactive “Pop-Up” Session

Led by:

Lani Hashimoto, Associate Director, Patient Engagement Management, Novartis

Devra Densmore, MPA, Founder & Principal Consultant, Elevate Advocacy, LLC

Jeff Evitts, SVP, Sales, AutoCruitment

Korinne Jew, Sr. Director, Enterprise Clinical Research & Medical Science, Medtronic

Rick Scorzetti, EVP, Chief Commercial Officer, Jumo Health

Tarra Shingler, Chief Commercial Officer, StudyKIK

Erica Smith, PhD, SVP, Business Development and Marketing, Spencer Health Solutions, Inc

Su Smith, Head of Patient Strategy, Origins

Participating Companies to date:

Showing Events in 1 Track from 12:35pm to 01:35pm

Luncheon, Networking and Optional Roundtable Discussions

12:35PM - 1:35PM

Luncheon, Networking and Optional Roundtable Discussions

Showing Events in 4 Tracks from 12:55pm to 01:35pm

Roundtable 1 (Liberty A)

#1. Establishing a Patient-Centric Culture in Biotech Start-ups: Integrating Advocacy into Corporate Ethos

Regan Sherman, Former Senior Director & Head, Patient Advocacy, Entrada Therapeutics

Roundtable 2 (Liberty B)

#2: Collaborating with Patients to Amplify Patient Engagement Insights in Peer-Reviewed Publications

Lisa Shea, MPH, RD, Director, Scientific Patient Engagement Research Leader, J&J Innovative Medicine

Roundtable 3 (Liberty C)

#3: Synergizing Patient Engagement and DE&I Functions for Inclusivity and Impact

Tracy Artim, MSN, CRNP, Director, Operational Design & Patient Engagement, Global Development Operations, Amgen

Racquel Racadio, MPH, Global Director, External Medical Engagement, Global Medical Organization, Amgen

Roundtable 4 (Liberty D)

#4: Beyond Trials: Nurturing Sustainable Relationships with Patient Communities for Clinical Research Initiatives

Amy McCormick, Senior Manager, Global Trial Optimization – Patient Engagement & Diversity, Equity and Inclusion (DEI), Regeneron Pharmaceuticals Inc

Kristin Parkhurst, Associate Director, Global Trial Optimization – Diversity, Equity and Inclusion (DEI) | Development Operations & Portfolio Management, Regeneron Pharmaceuticals Inc

Showing Events in 2 Tracks from 01:40pm to 03:00pm

Track 1: Impact Measures (Liberty AB)

Track Chair:

Nisha Patel, MBA, Engagement Director, Global Clinical Operations, GSK

Establishing KPIs and Metrics that Reflect Value and Impact of Patient Engagement Across R&D

Beth Brooks, Head, Patient Insights and Behavioral Sciences (PIBS), Sanofi

Heather Pin, Head, Patient Centric Operational Effectiveness | Patient Informed Development & Health Value Translation, Sanofi

Incorporating Quantitative Values of Patient Perspectives into Clinical Trial Design

Barry Liden, JD, Director, Public Policy, USC Schaeffer Center for Health Policy & Economics

Assessing the Impact of Patient Perspectives in Drug Development: An Amgen Case Study

Tracy Artim, MSN, CRNP, Director, Operational Design & Patient Engagement, Global Development Operations, Amgen

Turning Insights into Action: Integrating the Patient and Site Voice into Clinical Development

Annie Gilbert, Global Patient and Site Engagement Lead, Boehringer Ingelheim

Track 2: Early Engagement & Operationalizing Patient Engagement (Liberty CD)

Track Chair:

Eugenia Pankow, US Lead Research & Development Advocacy, Servier Pharmaceuticals

Maximizing Impact and Decision-Making through Early Development Patient Insights

Angela Bilkhu, Senior Global Patient Partnership Director, Hematology Product Development: Medical Affairs, Genentech

Strategically Integrating Patient and Study Coordinator Panels Across All Program Teams, Elevating Clinical Trial Efficiency and Outcomes from Early Study Design Onwards

Swathi Ramesh, Director, Patient Insights and Solutions, AstraZeneca

Bridging the Gap Between Clinical Trial Study Teams and Patient Perspectives: Gilead's Human-Centered Value Story Framework

Angi Gillen, MS, Senior Director, Head of Patient Experience, Global Development | Clinical Operations, Gilead Sciences

A Collaborative Approach to Supporting Patients and Physicians through the Study Protocol

Jarrod Longcor, Chief Operating Officer, Cellectar Biosciences

Maggie McGuire-Kuhl, VP of Research Engagement, The Michael J Fox Foundation (MJFF)

Erica Mercado, Account Director, BBK, Publicis Health

Showing Events in 1 Track from 03:00pm to 03:30pm

Afternoon Break and Networking

3:00PM - 3:30PM

Afternoon Break and Networking

Showing Events in 2 Tracks from 03:30pm to 04:25pm

Track 1: Solutions and Technologies that Support DE&I, Flexible Clinical Trials and Patient Services (Liberty AB)

Track Chair:

Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes

3:30PM - 3:45PM

Clinical Trial Decision Making: Learnings from a Social Sciences Study & A Collaborative Community-Based Diversity Program

Victoria DiBiaso, MPH, VP, Head of Patient Informed Development & Health Value Translation, Sanofi

Emily Idoni, Group Account Director, Publicis Health

3:45PM - 4:00PM

Closing the Diversity Gap: Strategies for Expanding Inclusion and Addressing Data Privacy Concerns

Xoli Belgrave, Senior Director, Global Head of Patient Inclusion, Parexel

4:00PM - 4:15PM

Using Simulations to Gain Patient Insight in Clinical Trials

Rachael MacQueen, MBA, Sr. Manager, Patient Centricity, Patient & Site Experience (PASE), Moderna

Stephanie Terrey, Senior Director, Patient Experience, CorEvitas, a part of Thermo Fisher Scientific

Track 2: Solutions And Technologies That Support DE&I, Flexible Clinical Trials And Patient Services (Liberty CD)

Track Chair:

Barry Nelson, Patient, Advocate

3:30PM - 3:55PM

Strategic Transformation: Advancing Clinical Trials through Innovative Site Network Commercial Models at a Portfolio Level

Samir Shah, Principle, Shah Pharma Consulting Services LLC

EB McLindon, CEO, Helios Clinical

Carlos Orantes, CEO, Alcanza Clinical

Mark Scullion, CEO, Atlas Clinical Research

3:55PM - 4:10PM

Patient Engagement Game Show: Fitting Methods for Patient Involvement in Research Methods

Jennifer Horonjeff, PhD, Founder & CEO, Savvy Cooperative

4:10PM - 4:25PM

Implementing a Patient-Focused Drug Development Framework for Enhanced Patient-Centric Strategies

Angela Wheeler, President, Strategy & Insight USA, Lead, Patient Center of Excellence, Lumanity

Showing Events in 1 Track from 04:25pm to 06:30pm

Day 1 Afternoon General Session (Liberty ABCD)

4:25PM - 4:35PM

10 Minute Health Break

4:35PM - 5:30PM

Community-based Organizations’ Insights into Enhancing Clinical Research Initiatives: Recommendations for Trial Sponsors

Ash Rishi, Founder & Chair of the Board of Trustees, Demand Diversity, a part of COUCH Health

Panelist:

Gary Ho, Patient Advocate and Co-founder, Gout Support Group of America

Sabina Kineen, Patient, Advocate

Stacey Langley, Patient, Advocate

Rucha Shah, Patient Advocate, and Assistant Clinical Research Project Manager, ECOG-ACRIN Cancer Research Group

Desiree A. H. Walker, Board President, Young Survival Coalition

5:30PM - 6:30PM

End of Day One and Annual Networking Reception

5:45PM - 6:30PM

Fundraising Activity for the Philadelphia Ronald McDonald House for Families Fighting Cancer

With:

Showing Events in 1 Track from 07:45am to 08:50am

Day 1 Morning General Session

7:45AM - 8:40AM

Registration, Tea/Coffee

8:40AM - 8:50AM

Co-Chair’s Welcome & Opening Remarks

Co-Chairs:

Ebony Dashiell-Aje, PhD, Executive Director, Patient Centered Outcomes Science (PCOS), BioMarin Pharmaceutical Inc

Ricki Fairley, MBA, CEO, TOUCH, The Black Breast Cancer Alliance

Showing Events in 1 Track from 08:50am to 09:40am

Morning Keynotes

8:50AM - 9:15AM

PATIENT KEYNOTE: The Personal Impact of a Clinical Trial

Irisaida Mendez, Patient, Advocate

Karen Peterson, Founder and Chief Patient Advocate, Karen's Club

9:15AM - 9:40AM

Keynote: Decoding the Evolution of Patient Advocacy - A Decade of Progress

Roslyn Schneider, MD, MSc, FACP, FCCP, VP, Head of Global Patient Affairs, BioMarin Pharmaceutical Inc

Showing Events in 1 Track from 09:40am to 10:20am

Grand Opening of the Patients as Partners Exhibits

9:40AM - 10:20AM

Grand Opening of the Patients as Partners Exhibits, Networking and Breakfast

Showing Events in 1 Track from 10:20am to 12:35pm

Day 1 Morning Sessions Continued

10:20AM - 11:00AM

ASK THE PATIENTS: Patient and Caregiver Perspectives on Navigating Clinical Trials and Insights for Future Progress

Jaye Bea Smalley, Head, Patient Advocacy, Immunovant

Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes

Patrick Gee Sr, PhD, JLC, Patient Advocate, Founder & Chief Executive Hope Dealer, iAdvocate, Inc

Yvonne McLean Florence, MDiv, Patient Advocate and 2023 Elevate Ambassador, National Coalition for Cancer Survivorship

Emily Parks, Patient Advocate and Founder, POP!

11:00AM - 12:00PM

INTERACTIVE SESSION: Defining What Success Looks like for Engaging Participants and Enhancing Collaborations in Clinical Trials

Jamie Goldfarb, Patient, Advocate

Nisha Patel, MBA, Engagement Director, Global Clinical Operations, GSK

Peter Schaeffer, MBA, Digital and Process Optimization Leader, GSK

12:00PM - 12:05PM

Patients as Partners 5-Min Health Break

12:05PM - 12:35PM

Reducing Patient Burden: An Interactive “Pop-Up” Session

Led by:

Lani Hashimoto, Associate Director, Patient Engagement Management, Novartis

Devra Densmore, MPA, Founder & Principal Consultant, Elevate Advocacy, LLC

Jeff Evitts, SVP, Sales, AutoCruitment

Korinne Jew, Sr. Director, Enterprise Clinical Research & Medical Science, Medtronic

Rick Scorzetti, EVP, Chief Commercial Officer, Jumo Health

Tarra Shingler, Chief Commercial Officer, StudyKIK

Erica Smith, PhD, SVP, Business Development and Marketing, Spencer Health Solutions, Inc

Su Smith, Head of Patient Strategy, Origins

Participating Companies to date:

Showing Events in 1 Track from 12:35pm to 01:35pm

Luncheon, Networking and Optional Roundtable Discussions

12:35PM - 1:35PM

Luncheon, Networking and Optional Roundtable Discussions

Showing Events in 4 Tracks from 12:55pm to 01:35pm

Roundtable 1 (Liberty A)

#1. Establishing a Patient-Centric Culture in Biotech Start-ups: Integrating Advocacy into Corporate Ethos

Regan Sherman, Former Senior Director & Head, Patient Advocacy, Entrada Therapeutics

Roundtable 2 (Liberty B)

#2: Collaborating with Patients to Amplify Patient Engagement Insights in Peer-Reviewed Publications

Lisa Shea, MPH, RD, Director, Scientific Patient Engagement Research Leader, J&J Innovative Medicine

Roundtable 3 (Liberty C)

#3: Synergizing Patient Engagement and DE&I Functions for Inclusivity and Impact

Tracy Artim, MSN, CRNP, Director, Operational Design & Patient Engagement, Global Development Operations, Amgen

Racquel Racadio, MPH, Global Director, External Medical Engagement, Global Medical Organization, Amgen

Roundtable 4 (Liberty D)

#4: Beyond Trials: Nurturing Sustainable Relationships with Patient Communities for Clinical Research Initiatives

Amy McCormick, Senior Manager, Global Trial Optimization – Patient Engagement & Diversity, Equity and Inclusion (DEI), Regeneron Pharmaceuticals Inc

Kristin Parkhurst, Associate Director, Global Trial Optimization – Diversity, Equity and Inclusion (DEI) | Development Operations & Portfolio Management, Regeneron Pharmaceuticals Inc

Showing Events in 2 Tracks from 01:40pm to 03:00pm

Track 1: Impact Measures (Liberty AB)

Track Chair:

Nisha Patel, MBA, Engagement Director, Global Clinical Operations, GSK

Establishing KPIs and Metrics that Reflect Value and Impact of Patient Engagement Across R&D

Beth Brooks, Head, Patient Insights and Behavioral Sciences (PIBS), Sanofi

Heather Pin, Head, Patient Centric Operational Effectiveness | Patient Informed Development & Health Value Translation, Sanofi

Incorporating Quantitative Values of Patient Perspectives into Clinical Trial Design

Barry Liden, JD, Director, Public Policy, USC Schaeffer Center for Health Policy & Economics

Assessing the Impact of Patient Perspectives in Drug Development: An Amgen Case Study

Tracy Artim, MSN, CRNP, Director, Operational Design & Patient Engagement, Global Development Operations, Amgen

Turning Insights into Action: Integrating the Patient and Site Voice into Clinical Development

Annie Gilbert, Global Patient and Site Engagement Lead, Boehringer Ingelheim

Track 2: Early Engagement & Operationalizing Patient Engagement (Liberty CD)

Track Chair:

Eugenia Pankow, US Lead Research & Development Advocacy, Servier Pharmaceuticals

Maximizing Impact and Decision-Making through Early Development Patient Insights

Angela Bilkhu, Senior Global Patient Partnership Director, Hematology Product Development: Medical Affairs, Genentech

Strategically Integrating Patient and Study Coordinator Panels Across All Program Teams, Elevating Clinical Trial Efficiency and Outcomes from Early Study Design Onwards

Swathi Ramesh, Director, Patient Insights and Solutions, AstraZeneca

Bridging the Gap Between Clinical Trial Study Teams and Patient Perspectives: Gilead's Human-Centered Value Story Framework

Angi Gillen, MS, Senior Director, Head of Patient Experience, Global Development | Clinical Operations, Gilead Sciences

A Collaborative Approach to Supporting Patients and Physicians through the Study Protocol

Jarrod Longcor, Chief Operating Officer, Cellectar Biosciences

Maggie McGuire-Kuhl, VP of Research Engagement, The Michael J Fox Foundation (MJFF)

Erica Mercado, Account Director, BBK, Publicis Health

Showing Events in 1 Track from 03:00pm to 03:30pm

Afternoon Break and Networking

3:00PM - 3:30PM

Afternoon Break and Networking

Showing Events in 2 Tracks from 03:30pm to 04:25pm

Track 1: Solutions and Technologies that Support DE&I, Flexible Clinical Trials and Patient Services (Liberty AB)

Track Chair:

Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes

3:30PM - 3:45PM

Clinical Trial Decision Making: Learnings from a Social Sciences Study & A Collaborative Community-Based Diversity Program

Victoria DiBiaso, MPH, VP, Head of Patient Informed Development & Health Value Translation, Sanofi

Emily Idoni, Group Account Director, Publicis Health

3:45PM - 4:00PM

Closing the Diversity Gap: Strategies for Expanding Inclusion and Addressing Data Privacy Concerns

Xoli Belgrave, Senior Director, Global Head of Patient Inclusion, Parexel

4:00PM - 4:15PM

Using Simulations to Gain Patient Insight in Clinical Trials

Rachael MacQueen, MBA, Sr. Manager, Patient Centricity, Patient & Site Experience (PASE), Moderna

Stephanie Terrey, Senior Director, Patient Experience, CorEvitas, a part of Thermo Fisher Scientific

Track 2: Solutions And Technologies That Support DE&I, Flexible Clinical Trials And Patient Services (Liberty CD)

Track Chair:

Barry Nelson, Patient, Advocate

3:30PM - 3:55PM

Strategic Transformation: Advancing Clinical Trials through Innovative Site Network Commercial Models at a Portfolio Level

Samir Shah, Principle, Shah Pharma Consulting Services LLC

EB McLindon, CEO, Helios Clinical

Carlos Orantes, CEO, Alcanza Clinical

Mark Scullion, CEO, Atlas Clinical Research

3:55PM - 4:10PM

Patient Engagement Game Show: Fitting Methods for Patient Involvement in Research Methods

Jennifer Horonjeff, PhD, Founder & CEO, Savvy Cooperative

4:10PM - 4:25PM

Implementing a Patient-Focused Drug Development Framework for Enhanced Patient-Centric Strategies

Angela Wheeler, President, Strategy & Insight USA, Lead, Patient Center of Excellence, Lumanity

Showing Events in 1 Track from 04:25pm to 06:30pm

Day 1 Afternoon General Session (Liberty ABCD)

4:25PM - 4:35PM

10 Minute Health Break

4:35PM - 5:30PM

Community-based Organizations’ Insights into Enhancing Clinical Research Initiatives: Recommendations for Trial Sponsors